EPISODE · Dec 1, 2025 · 31 MIN
Patients Progressing on an AI ± CDK4/6 Inhibitors: From Biomarkers to Treatment Strategies
from Keeping Current CME
Did you know that the prevalence of acquired ESR1 mutations increases after exposure to endocrine therapy? Credit available for this activity expires: 11/26/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-copd-care-through-precision-medicine-and-patient-2025a1000x00?ecd=bdc_podcast_libsyn_mscpedu
Embed this episode
NOW PLAYING
Patients Progressing on an AI ± CDK4/6 Inhibitors: From Biomarkers to Treatment Strategies
0:00
31:58
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Keeping Current CME?
This episode is 31 minutes long.
When was this Keeping Current CME episode published?
This episode was published on December 1, 2025.
Can I download this Keeping Current CME episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!